Neurology News

As the Supreme Court prepares to rule on race-conscious admissions policies at universities, the AMA adopted a new policy of its own that recognizes the importance of considering race in admissions to diversify the workforce.

The AMA adopted policy advocating for greater regulatory oversight of insurers’ use of artificial intelligence at its annual House of Delegates meeting.

A Bay Area bioelectronic medicine company announced the commercial launch of its next-generation Cala kIQ System, an FDA-cleared wearable device to relieve hand tremors in people with essential tremor and Parkinson’s disease.

SAN FRANCISCO — Among patients with multiple sclerosis, cognitive function was predicted by age, depressive symptoms and anxiety, according to a poster presented at the American Psychiatric Association annual meeting.

PHILADELPHIA — Direct oral anticoagulants for stroke prevention in patients with atrial fibrillation are safe in most high-risk populations, a speaker said during the Heart in Diabetes CME Conference.

Adolescents can overcome circadian phase delay and boost their sleep duration with an earlier bedtime, according to a study published in Pediatrics.

INDIANAPOLIS — For adults with narcolepsy, a switch in treatment to Xywav was safe, efficacious and preferred over treatment with Xyrem on a gram-for-gram basis, according to Wayne Macfadden, MD, in a Healio video from SLEEP 2023.

MIAMI BEACH, Fla. — Treatment with ketamine may be an effective augmenter of risk mitigation for suicidality and effective modulator for suicide-related cognitive processing in adults, according to data presented here.

The American Academy of Neurology has submitted a formal national coverage determination reconsideration request to CMS regarding current coverage of amyloid-targeting monoclonal antibodies for Alzheimer’s disease, including Leqembi.

Jesse M. Ehrenfeld, MD, MPH, FAMIA, FASA, was recently sworn in as president of the AMA.